Natera (NTRA) Cash from Investing Activities Growth (3y) (2017 - 2026)
Natera (NTRA) Cash from Investing Activities Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 41.86% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -47.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.07% |
| Dec 31, 2025 | -73.98% |
| Sep 30, 2025 | -31.98% |
| Jun 30, 2025 | -39.02% |
| Mar 31, 2025 | -27.68% |
| Dec 31, 2024 | -28.86% |
| Sep 30, 2024 | 28.03% |
| Jun 30, 2024 | -36.34% |
| Mar 31, 2024 | 16.81% |
| Dec 31, 2023 | 30.91% |
| Sep 30, 2023 | 39.88% |
| Jun 30, 2023 | 31.72% |
| Mar 31, 2023 | -28.54% |
| Dec 31, 2022 | 28.31% |
| Sep 30, 2022 | 43.20% |
| Jun 30, 2022 | 32.85% |
| Mar 31, 2022 | 152.13% |
| Dec 31, 2021 | 54.19% |
| Sep 30, 2021 | -92.44% |
| Jun 30, 2021 | 90.86% |